In this episode, AGG Healthcare Litigation co-chair Jason Bring continues his discussion on agency deference with AGG Healthcare Litigation partner Brian Stimson in the aftermath of the Supreme Court’s opinion in Loper Bright Enterprises, Inc. v. Raimondo, which overruled Chevron deference. Jason and Brian address how this ruling will affect healthcare litigation and impact agency behavior going forward. They also discuss how the Supreme Court seems to be signaling the return of authority from the Executive Branch to the courts and the Legislature.
The discussion focuses on the implications of the Supreme Court’s decision in Loper Bright Enterprises, Inc. v. Raimondo for healthcare litigation. Jason and Brian explore the potential impact on future cases involving regulatory agencies and how this change in deference could influence the outcomes of disputes in the healthcare industry.
Furthermore, the conversation delves into the broader implications of the Supreme Court’s decision on agency behavior moving forward. Jason and Brian analyze how this shift in deference might prompt agencies to reconsider their approach to regulatory enforcement and decision-making processes.
Overall, the discussion underscores the evolving dynamics of agency deference in the legal landscape and highlights the potential ramifications for healthcare litigation and regulatory oversight. It also reflects on the larger trend of power distribution among branches of government and the implications for legal interpretation and enforcement.